CRP and rheumatoid arthritis: In addition, the use of the NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) effectively suppressed CRP-induced proliferation of RA-FLSs, supporting the therapeutic potential of targeting this pathway.